Identifying a Subgroup of High-Risk Prostate Cancer Patients With Worse Clinical Outcomes: Should There Be a "Very High-Risk" Group?

被引：0
|
作者：
Choi, S. [1 ]
Levy, L. B. [1 ]
Lee, K. K. [1 ]
Nguyen, Q. N.
Lee, A. K. [2 ,3 ]
McGuire, S. E. [1 ]
Kudchadker, R. [1 ]
Du, W. [1 ]
Hoffman, K. E. [1 ]
Mahmood, U. [1 ]
Frank, S. J. [1 ]
Kuban, D. A. [1 ]
机构：
[1] Univ Texas MD Anderson Canc Ctr, Div Radiat Oncol, Houston, TX 77030 USA
[2] Univ Texas MD Anderson Canc Ctr, Dept Radiat Oncol, Houston, TX 77030 USA
[3] Texas Ctr Proton Therapy, Irving, TX USA
来源：
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2016年 / 96卷 / 02期
关键词：
D O I：
10.1016/j.ijrobp.2016.06.1228
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2586
引用
收藏
页码：E240 / E241
页数：2
相关论文
共 50 条
  • [1] IMPACT OF EXTENDED PELVIC LYMPH NODE DISSECTION ON THE CLINICAL OUTCOMES OF HIGH-RISK AND VERY HIGH-RISK PROSTATE CANCER
    Lee, Hyung Ho
    Lim, Meng Shi
    Yu, Ho Song
    Bang, Woo Jin
    Rha, Koon Ho
    Hong, Sung Jun
    JOURNAL OF UROLOGY, 2012, 187 (04): : E314 - E314
  • [2] Clinical Outcomes of Very High-risk Prostate Cancer Treated with Proton Therapy
    Sosa, Alan
    Choi, Seungtaek
    Nguyen, Quynh-Nhu
    Kudchadker, Reena
    Sanders, Jeremiah
    Zhu, Ronald
    Shah, Shalin
    Mok, Henry
    Kuban, Deborah
    Mayo, Lauren
    Hoffman, Karen
    Tang, Chad
    McGuire, Sean
    Ausat, Noveen
    Thames, Howard
    Frank, Steven
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2022, 45 (09): : S5 - S5
  • [3] Feeding the Controversy: When Pelvic Irradiation Improves Outcomes in High-Risk and Very High-Risk Prostate Cancer
    Jan, Imraan
    Parikh, Rahul R.
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (11) : 1196 - +
  • [4] Obstructive sleep apnoea outcomes after surgery: identifying high-risk patients from a high-risk group
    Liddicoat, P.
    Duffen, A.
    Howes, H.
    Hood, E.
    Wilson, H.
    ANAESTHESIA, 2023, 78 : 31 - 31
  • [5] Oncological and functional outcomes of high-risk and very high-risk prostate cancer patients after robot-assisted radical prostatectomy
    Chen, Wei-Hsin
    Lee, Yu Khun
    Kuo, Hann-Chorng
    Wang, Jen-Hung
    Jiang, Yuan-Hong
    PLOS ONE, 2023, 18 (03):
  • [6] Neoadjuvant and adjuvant chemohormonal therapy in patients with high-risk and very high-risk prostate cancer: our experience
    Ustinova, T., V
    Nyushko, K. M.
    Bolotina, L., V
    Kharchenko, N., V
    Paychadze, A. A.
    Taraki, I. A.
    Alekseev, B. Ya
    Krasheninnikov, A. A.
    Kaprin, A. D.
    ONKOUROLOGIYA, 2018, 14 (03): : 58 - 67
  • [7] Classifying high-risk versus very high-risk prostate cancer: is it relevant to outcomes of conformal radiotherapy and androgen deprivation?
    Saad, Akram
    Goldstein, Jeffrey
    Lawrence, Yaacov R.
    Spieler, Benjamin
    Leibowitz-Amit, Raya
    Berger, Raanan
    Davidson, Tima
    Urban, Damien
    Tsang, Lev
    Alezra, Dror
    Weiss, Ilana
    Symon, Zvi
    RADIATION ONCOLOGY, 2017, 12
  • [8] Classifying high-risk versus very high-risk prostate cancer: is it relevant to outcomes of conformal radiotherapy and androgen deprivation?
    Akram Saad
    Jeffrey Goldstein
    Yaacov R. Lawrence
    Benjamin Spieler
    Raya Leibowitz-Amit
    Raanan Berger
    Tima Davidson
    Damien Urban
    Lev Tsang
    Dror Alezra
    Ilana Weiss
    Zvi Symon
    Radiation Oncology, 12
  • [9] clinical outcomes of radiation therapy for high-risk prostate cancer
    Gumenetskaya, Y.
    Makarova, K.
    Biryukov, V.
    RADIOTHERAPY AND ONCOLOGY, 2021, 158 : S208 - S208
  • [10] Use of biopsy detail to identify subgroup risk in high-risk patients with prostate cancer
    Townsend, Natasha C.
    Buyyounouski, Mark K.
    Ruth, Karen J.
    Kutikov, Alexander
    Viterbo, Rosalia
    Sobczak, Mark
    White, Terry
    Horwitz, Eric M.
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (06)
12345